Google DeepMind Launches AlphaGenome Atlas for DNA Mapping
Google DeepMind has launched AlphaGenome Atlas, a new database that maps how genetic mutations in non-coding DNA affect human molecular biology.
What happened?
Google DeepMind has unveiled AlphaGenome Atlas, a comprehensive database that maps the impact of genetic mutations on human molecular biology with high resolution. The human genome consists of approximately 3 billion base pairs, of which only 2 per cent code for proteins. AlphaGenome Atlas predicts the effects of alterations in the remaining 98 per cent of the genome, which have previously been largely uncharted.
Key facts
| Lanseringsdatum | 8 september 2026 |
|---|---|
| Antal baspar i människans genom | Cirka 3 miljarder |
| Andel protein-kodande DNA | 2 % |
| Andel icke-kodande DNA | 98 % |
Why it matters
While science has developed a solid understanding of the protein-coding sections of the genome, the mechanisms within non-coding DNA have proven difficult to analyse. By predicting how individual changes in these regions disrupt molecular processes, such as protein production, AlphaGenome Atlas provides a holistic view that could accelerate the discovery of new treatments.
Who is affected?
The tool is aimed at researchers in genetics, biotechnology, and medical development. Pharmaceutical companies and academic institutions can use the database to identify links between non-coding DNA mutations and various disease states.
Impact on the EU
AlphaGenome Atlas is globally available via Google DeepMind's platform for researchers worldwide, including research institutes within the EU. As the tool is used as an open research database in the academic sector, it is primarily influenced by the EU's frameworks regarding open data and research collaboration.
What else you should know
The launch of the database builds on previous breakthroughs with the AlphaGenome model and aims to accelerate the understanding of how point mutations lead to complex diseases. Researchers can now look up and analyse specific DNA sequences without the need to run their own heavy computational models from scratch.
Quick answers about this story
Vad har hänt?
När hände det?
Varför spelar det roll?
Vilka berörs av verktyget?
The link opens in a new window and leads to the publisher's own site.
Källan har spårats automatiskt från utgivaren via Aheadlines signalkedja.
AI-verktyg i artikeln
Topics
Get similar news straight to your inbox
The reader's room
Send in a question or an addition. The newsroom reads everything before it's published and replies when relevant. No AI-generated text – just people.
Sign in to submit a comment or question.
Read the article through your role
- Decide whether this affects strategy over 6–12 months or is just noise.
- Discuss with leadership: do we own the right question or does ownership need to move?
- Ask: what risk are we taking by NOT acting on this this quarter?
Generated angle — not editorial analysis of "Google DeepMind Launches AlphaGenome Atlas for DNA Mapping"